Published in Adv Urol on August 29, 2011
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol (2001) 11.35
Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol (2007) 11.04
The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol (2009) 2.92
Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol (2004) 2.73
Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol (2001) 2.12
The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer (2008) 1.94
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol (2002) 1.90
Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol (2001) 1.86
Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol (2007) 1.74
Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004. J Urol (2009) 1.69
Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol (2004) 1.68
Superiority of ratio based lymph node staging for bladder cancer. J Urol (2003) 1.66
Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer (2008) 1.62
Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer (2006) 1.53
How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? J Urol (2009) 1.51
Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol (1996) 1.49
Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int (2000) 1.46
Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol (2001) 1.42
Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol (2003) 1.39
Pathologic evaluation of radical cystectomy specimens: a cooperative group report. Cancer (2004) 1.39
Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol (1998) 1.35
Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol (2004) 1.33
Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol (2003) 1.29
Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol (2008) 1.26
Comparison of laparoscopic and open radical cystoprostatectomy for localized bladder cancer with 3-year oncological followup: a single surgeon experience. J Urol (2007) 1.19
Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study--a single center experience. J Urol (2004) 1.16
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int (2010) 1.15
Regional lymph node metastasis from bladder cancer. J Urol (1981) 1.14
Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol (2005) 1.14
Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol (2006) 1.14
Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol (2005) 1.13
Transperitoneal endosurgical lymphadenectomy in patients with localized prostate cancer. J Urol (1991) 1.11
Regional gland dissection for carcinoma of the bladder; a technique for one-stage cystectomy, gland dissection, and bilateral uretero-enterostomy. J Urol (1950) 1.08
The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol (1993) 1.04
Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol (1982) 1.03
Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol (2004) 1.02
Lymphadenectomy in bladder cancer: how high is "high enough"? Urol Oncol (2006) 1.01
Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int (2004) 1.00
Open versus laparoscopy-assisted radical cystectomy: results of a prospective study. J Endourol (2007) 0.97
Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy. Anticancer Res (2010) 0.95
The lymph node yield during robot-assisted radical cystectomy. BJU Int (2008) 0.94
Pelvic lymph nodes: distribution and nodal tumour burden of urothelial bladder cancer. J Clin Pathol (2010) 0.93
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer. BJU Int (2008) 0.89
The role of lymph node density in bladder cancer prognostication. World J Urol (2008) 0.88
Hospital lymph node counts and survival after radical cystectomy. Cancer (2008) 0.86
Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases? World J Urol (2009) 0.86
Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer. Urology (2009) 0.86
Does extended lymphadenectomy preclude laparoscopic or robot-assisted radical cystectomy in advanced bladder cancer? Curr Opin Urol (2009) 0.84
Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results. Surg Oncol Clin N Am (2007) 0.82
Lymphadenectomy with cystectomy: is it necessary and what is its extent? Eur Urol (2004) 0.80
The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience. Cancer (1994) 0.80
Relevance of extracapsular extension of pelvic lymph node metastasis in patients with bladder cancer treated in the contemporary era. Cancer (2006) 0.80
Pelvic lymphadenectomy during radical cystectomy: a review of the literature. Surg Oncol (2009) 0.79
The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer. J Urol (1973) 0.79
Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy specimens. BJU Int (2010) 0.78
Lymph-node revealing solution: a new method for detecting minute lymph nodes in cystectomy specimens. Br J Urol (1997) 0.78
Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference? World J Urol (2009) 0.78
Outcomes in patients with urothelial carcinoma of the bladder with limited pelvic lymph node dissection. BJU Int (2006) 0.78
Does 'extended' pelvic lymphadenectomy truly contribute to the management of bladder carcinoma? Eur Urol (1986) 0.76
The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre. BJU Int (2010) 1.03
Renal dysplasia with extrarenal calyces. Saudi Med J (2006) 1.02
Extended followup oncologic outcome of randomized trial between cryoablation and external beam therapy for locally advanced prostate cancer (T2c-T3b). J Urol (2012) 0.76